ALNY - Alnylam Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ALNY is currently covered by 26 analysts with an average price target of $199.97. This is a potential upside of $43.93 (28.15%) from yesterday's end of day stock price of $156.04.

Alnylam Pharmaceuticals's activity chart (see below) currently has 324 price targets and 334 ratings on display. The stock rating distribution of ALNY is 65.45% BUY and 34.55% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.89% with an average time for these price targets to be met of 217.18 days.

Highest price target for ALNY is $395, Lowest price target is $161, average price target is $199.97.

Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 27-Mar-2024.

Currently out of the existing stock ratings of ALNY, 72 are a BUY (65.45%), 38 are a HOLD (34.55%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

234

$77.96 (49.96%)

234

16 days ago

0/3 (0%)

$79.61 (51.56%)

Buy

235

$78.96 (50.60%)

235

1 months 23 days ago

2/14 (14.29%)

$85.31 (56.99%)

149

Buy

227

$70.96 (45.48%)

237

1 months 27 days ago

14/22 (63.64%)

$80 (54.42%)

171

Hold

161

$4.96 (3.18%)

171

1 months 27 days ago

2/2 (100%)

$14 (9.52%)

5

Buy

225

$68.96 (44.19%)

250

1 months 27 days ago

2/6 (33.33%)

$78 (53.06%)

435

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?

On average it took 217.18 days on average for the stock forecasts to be realized with a an average price target met ratio 74.89

Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?

MADHU KUMAR

Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on ALNY

Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?

Patrick Trucchio with highest potential upside - $238.96

Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?

Jami Rubin with lowest potential downside - -$94.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?